Drug or treatment

Finotonlimab clinical trials

As of November 12, 2026, Find a Trial lists 3 clinical trials of Finotonlimab that are recruiting, in China. 1 was first registered in the last 30 days. By phase: Phase 2 (1), Phase 1 (1), Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.

Newest trials

StudyPhaseWhereStatusRegistered
Neoadjuvant finotonlimab plus TP chemotherapy for SMARCB1-deficient sinonasal cancer Phase 2 Shanghai, Shanghai Municipality Recruiting Nov 10, 2026
Cetuximab with PD-1 therapy plus chemotherapy vs PD-1 therapy with chemotherapy for recurrent/metastatic head and neck cancer Phase 3 Shanghai, Shanghai Municipality and 1 other locations Recruiting Apr 3, 2026
Finotonlimab plus Stapokibart for recurrent or metastatic head and neck cancer Phase 1 Beijing, Beijing Municipality Recruiting Jun 26, 2025

All recruiting trials (3)

Quick answers

How many clinical trials of Finotonlimab are recruiting right now?

3, as of November 12, 2026. 1 of them was first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in China. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 1, Phase 1: 1, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →

Last reviewed 2026-11-12 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.